About 75% of all primary liver cancers in adults are HCC and up to 30% of HCC patients are eligible for embolisation
Keynote -564 is the first Phase 3 trial to demonstrate superior overall survival (OS) with adjuvant therapy compared to placebo in patients with RCC
Glenmark will be responsible for further developing, registering, and commercializing Envafolimab in India, Asia Pacific, Middle East and Africa, Russia, CIS, and Latin America
An accomplished R&D leader and champion of the application of AI to drug discovery
The orphan drug designation by the EC is issued for drugs which are intended to treat diseases that affect fewer than five in 10,000 people in the European Union
The bold, dynamic, and new logo unveiled in this process captures the essence of the 'Better Together' theme
Microdosing has emerged as a key trend in the pharmaceutical and nutritional markets
Lays foundation stone of NIPER Hyderabad and NIPER Raebareli
The Institute is catering the health needs of the surrounding population with ever-increasing OPD every year along with special OPDs like mother & Child OPD, and LSD clinic
HIFU is a state-of-the-art treatment that utilizes high-frequency sound waves to target and destroy prostate cancer cells
Subscribe To Our Newsletter & Stay Updated
